Search Results - erkki ruoslahti

24 Results Sort By:
Pulmonary and fibrotic disorder homing peptides
--> Peptides Diagnostics - Therapeutics Lead Inventor Erkki Ruoslahti, M.D., Ph.D. Ruoslahti lab homepage Selected References List of references via Pubmed Patent Information ...
Published: May 03, 2010   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Diagnostics, Therapeutics
Category(s): Peptides
Targeting of albumin-embedded taxol nanoparticles to tumors
--> Nanoparticle Cancer - Therapeutics Background Nanomedicine is an emerging field that uses nanoparticles to facilitate the diagnosis and treatment of diseases. Nanoparticles are attractive because multiple functions can be built into them, su...
Published: October 29, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Cancer, Therapeutics
Category(s): Nanoparticle
Cell migration inhibitors
--> Peptides Cancer - Therapeutics Synthetic peptides to inhibit cell migration or invasion. Lead Inventor Erkki Ruoslahti, M.D., Ph.D. Ruoslahti lab homepage Selected References List of references...
Published: October 09, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Cancer, Therapeutics
Category(s): Peptides
Nanoparticle delivery of clot binding compounds
--> Nanoparticles Cancer - Therapeutics A nanoparticle delivery system where the particles amplify their own homing by a modified clot-binding compound that can selectively bind to clotted plasma protein. Lead Inventor Erkki ...
Published: September 29, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Cancer, Therapeutics
Category(s): Nanoparticle
Bladder tumor targeting peptides
--> Peptides Cancer - Diagnostics - Therapeutics Bladder epithelium targeting peptides for the treatment of cancer Features · Non-invasive bladder cancer diagnostic tool · Selectivity of the homin...
Published: August 20, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Cancer, Diagnostics, Therapeutics
Category(s): Peptides
Tumor-penetrating peptides
--> Peptides Apoptosis - Cancer - Therapeutics Tissue selective homing peptides containing CENDR and iRDG elements to enhance internalization and penetration of compounds, for the treatment of cancer. Features ...
Published: July 23, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Apoptosis, Cancer, Therapeutics
Category(s): Peptides
Integrin binding proteins
--> Peptides Therapeutics Peptides specific for fibronectin and vitronectin binding integrins to modulate cell adhesion. Lead Inventor Erkki Ruoslahti, M.D., Ph.D. Ruoslahti lab homepage Sel...
Published: July 02, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Therapeutics
Category(s): Peptides
Organ homing peptides
--> Peptides Therapeutics Peptides that home to target organs to deliver a drug or therapeutics. Lead Inventor Erkki Ruoslahti, M.D., Ph.D. Ruoslahti lab homepage Selected References ...
Published: June 29, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Therapeutics
Category(s): Peptides
Cyclical peptides to modulate integrin ligand binding
--> Peptides Bone Disorders - Cancer - Immunology and Inflammation - Thrombosis Cyclic peptides that mimic the integrin site to modulate the activities of RGD-binding integrins to reduce or inhibit cell attachment. Lead Inventor Erkki Ruoslahti, M.D., Ph....
Published: June 29, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Bone Disorders, Cancer, Immunology & Inflammation, Thrombosis
Category(s): Peptides
Tumor vasculature homing peptides
--> Peptides Cancer - Therapeutics Peptides that home to the vasculature of tumors to treat cancer. Lead Inventor Erkki Ruoslahti, M.D., Ph.D. Ruoslahti lab homepage Selected References List of references...
Published: June 29, 2009   |   Inventor(s): Erkki Ruoslahti
Keywords(s): Cancer, Therapeutics
Category(s): Peptides
1 2 3